Access comprehensive financial analyses and make smarter investments - get the Manual of Investments on Amazon!

IPG Photonics Q1 Revenue Up 17% to $265.5M

IPG Photonics started 2026 with first-quarter revenue of $265.5 million, up 17% from $227.8 million a year earlier, marking its second straight quarter of double-digit year-over-year sales growth.

Industrial solutions drove the improvement, rising 21% to $227.6 million from $188.0 million and accounting for 86% of total revenue. Advanced solutions fell 5% to $37.9 million from $39.8 million.

By geography, sales increased 27% in North America, 14% in Asia and 4% in Europe.

Gross margin narrowed to 37.5% from 39.4%, while adjusted gross margin slipped to 37.8% from 40.0%. The company said tariffs and higher product costs pressured margins, partly offset by lower inventory provisions.

Operating results swung to a loss of $7.7 million from operating income of $1.8 million a year ago. Operating margin turned negative at 2.9%, compared with positive 0.8% in the prior-year quarter.

Net income declined 58% to $1.6 million from $3.8 million, and diluted earnings per share fell 56% to $0.04 from $0.09.

Adjusted EBITDA increased 8% to $35.2 million from $32.7 million, while adjusted diluted EPS edged down 6% to $0.29 from $0.31.

Capital spending totaled $16 million in the quarter.

For the second quarter, IPG projected revenue of $260 million to $290 million, adjusted gross margin of 37% to 40%, adjusted operating expenses of $92 million to $95 million, adjusted diluted EPS of $0.25 to $0.55, and adjusted EBITDA of $32 million to $48 million. The market has reacted to these announcements by moving the company's shares -22.63% to a price of $94.65. If you want to know more, read the company's complete 8-K report here.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS